Chemed Corporation reported solid financial results for Q2 2026, driven by growth in both its VITAS hospice care segment and its Roto-Rooter home services segment. The company continues to navigate regulatory complexities, notably Medicare reimbursement dependency and franchising regulations, while maintaining strong brand moats and decentralized operational control. Labor market pressures and competition remain notable risks, particularly in the fragmented home services space. Chemed’s ability to balance capital allocation between its healthcare and home repair businesses, alongside managing workforce training and safety programs, will be key to sustaining its growth trajectory.